WebBioLife4D Corp. filed its S-1 (prospectus) on June 3, 2024. The company’s IPO is a unit offering consisting of stock and warrants. ... (Wall Street Consensus of Opening-day … WebCompany surpasses $1M in accepted investments; expects to make significant scientific announcement in the near future CHICAGO – June 22, 2024 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying its Regulation A+ (Mini-IPO) offering, …
Biotech Pioneer BIOLIFE4D Submits Regulation A
WebDec 23, 2024 · Bioengineered heart developer Biolife4D ( SAVU) has upsized its proposed initial public offering to $23M from $15M. The biotech company said in a filing that it is now looking to offer 3.2M units ... WebNov 13, 2024 · BIOLIFE4D has filed a $50 million initial public offering with the Securities and Exchange Commission (SEC) under Regulation A+ equity crowdfunding rules, allowing everyday investors to help the ... story histoire cousine
BIOLIFE4D Proceeding on Mission to Bioprint Human Hearts, Taps ...
WebMar 14, 2024 · BIOLIFE4D’s plans for an IPO are detailed in the S-1 registration statement it submitted to the SEC last week. In what is a lengthy document, the firm outlines how it … WebSep 11, 2024 · BIOLIFE4D has now filed a $50 million initial public offering with the Securities and Exchange Commission (SEC) under Regulation A+ rules, meaning that everyday investors can help the company ... WebSep 7, 2024 · /PRNewswire/ -- BIOLIFE4D announced it filed a $50 million initial public offering with the Securities and Exchange Commission (SEC) under Regulation A+ rules,... storyhive summer crew